CClinicalTrials.gg
WithdrawnNCT00285493Updated Mar 13, 2014

Low Back Pain and Antibiotic Treatment

A Phase 1 interventional study of Antibiotics in Low Back Pain, sponsored by Loewenstein Hospital. Withdrawn. Open to participants aged 25 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-03-13.

Sponsored by Loewenstein Hospital · Phase 1, Interventional, and Treatment

Why this study was withdrawn
Withdrawn: study halted prematurely, prior to enrollment of first participant
Phase
Phase 1
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
25 Years to 85 Years
Sex
All
01

Study summary

Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

Read the detailed description

Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

02

Conditions studied

  • Low Back Pain

Keywords

  • low back pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

Browse Back Pain studies →

Lead sponsor

Loewenstein Hospital is the lead sponsor of 24 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Must be able to swallow tablets

Exclusion criteria

Exclusion Criteria:

  • Allergy to antibiotics
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Interventions

  • DrugAntibiotics
06

What researchers measure

Primary outcomes

  1. protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00285493
Lead sponsor
Loewenstein Hospital
Collaborators
Clalit Health Services
First posted
Feb 2, 2006
Start date
Jan 2006
Primary completion
Feb 2006
Completion
Feb 2006
Last update
Mar 13, 2014

Study contacts

Bambi Alyagon, MSc
study director · Loewenstein Hospital
Shoshana Weiler, MD
principal investigator · Loewenstein Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion